Review ArticleInternational Journal of Pharmaceutical InvestigationVol. 15 | Issue 3 | 2025 | pp. 698–702Open access
The Prevalence of Kounis Syndrome and COVID-19 Vaccination-A Comprehensive Review
- 1*,
- 1,
- 1,
- 1
- 1 Department of Pharmacy Practice, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, (SIMATS-Deemed to be University), Chennai, Tamil Nadu, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Bhavya Ekambaram
Department of Pharmacy Practice, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, (SIMATS-Deemed to be University), Chennai, Tamil Nadu, INDIA.
Email: bhavyae.scop@saveetha.com
Copyright: © 2025 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2025
- Received:
- Nov 29, 2024
- Accepted:
- Mar 7, 2025
- DOI:
- 10.5530/ijpi.20250210
How to cite
Ekambaram, B., Suresh, S., John, J. F., & Kamaraj, N. K. J. (2025). The Prevalence of Kounis Syndrome and COVID-19 Vaccination-A Comprehensive Review. International Journal of Pharmaceutical Investigation, 15(3), 698–702. https://doi.org/10.5530/ijpi.20250210
Abstract
Background
Kounis Syndrome (KS) or allergic myocardial infarction is a rare, complicated Coronary Artery syndrome (CAD) which develops concurrently with an allergy or hypersensitivity reaction. It is also termed as Allergic Angina or Allergic Myocardial Infarction. The Coronary Artery Disease (CAD) is caused by Atherosclerotic plaque accumulation, a condition in which the coronary arteries that deliver blood, oxygen and nutrients to the heart muscle constrict or become clogged due to this, blood supply to the heart is reduced which can cause angina (chest discomfort) and dyspnea. The syndrome has well-defined clinical and diagnostic significance highlighting the involvement of inflammatory mediators in cardiovascular pathology.
Objectives
To provide an overview on the pathophysiology, classification, triggers, clinical presentation, diagnosis, treatment and prognosis of Kounis Syndrome.
Materials and Methods
A review of current literature on the mechanisms, clinical features and management strategies for KS, focusing specifically on the need for simultaneity in the recognition of allergic and coronary symptoms.
Results
Kounis Syndrome (KS) is a rare condition where Acute Coronary Syndromes (ACS) is linked to allergic reactions. This happens because substances like histamine and tryptase are released. There are 3 types: vasospasm without Coronary Artery Disease (CAD), plaque disruption with existing CAD and hypersensitivity causing stent thrombosis. Triggers can be drugs, foods, insect bites, or environmental allergens. Symptoms include chest pain, ECG changes and allergic signs like rash and anaphylaxis. Diagnosis involves looking at the patient's history, identifying the allergen and checking for signs of ischemia and allergic reaction. Treatment includes antihistamines, corticosteroids, epinephrine (used carefully) and standard ACS treatments. The outcome depends on how much the coronary arteries are affected and the severity of the reaction.
Conclusion
Kounis Syndrome is an allergy and cardiovascular pathology which indicates their connection. More public awareness through the medical community and the provision of better reporting are surely crucial in order to have more information of its epidemiology and adequate patient care. More studies should be carried out to elucidate the mechanisms and to prescribe effective treatments in the case of Kounis Syndrome.
Keywords
Subject
Article metadata
| Title | The Prevalence of Kounis Syndrome and COVID-19 Vaccination-A Comprehensive Review |
|---|---|
| Authors | Bhavya Ekambaram; Swetha Suresh; Jerphene Franklin John; Nithish Kumar Jothi Kamaraj |
| Affiliations | Department of Pharmacy Practice, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, (SIMATS-Deemed to be University), Chennai, Tamil Nadu, INDIA. |
| Corresponding author | bhavyae.scop@saveetha.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 15, Issue 3 (2025) |
Also in this issue
- Exploring the Healing Paths: Navigating Complementary and Alternative Medicinepp. 675–688
- A Pathway to Natural Cancer Therapy; Exploring Zerumbone’s Multitargeted Anticancer Actionspp. 689–697
- Exploring the Potential of Gastro Retentive Drug Delivery Systems: An Insightful Perspectivepp. 703–724
- Innovative Approaches for the Extraction, Purification, and Quantification of Polyphenols: A Comprehensive Reviewpp. 725–739
- Regulatory and Quality Aspects of Bio Absorbable Bandages for Intestinal Wound Healingpp. 740–747